Krishana Phoschem DuPont analysis

·UnclassifiedChart ›
Per cent unless marked ×
Tap a line for its trendLast 12Mto Jun 2026FY26Mar 2026FY25Mar 2025FY24Mar 2024FY23Mar 2023FY22 and earlierAlpha Plus
5-step DuPont — ROE = tax burden × interest burden × EBIT margin × turnover × leverage
FY22 and earlierEvery year the company has filed comes with Alpha Plus.
0.79×0.75×0.70×0.68×0.69×
0.89×0.91×0.81×0.62×0.91×
11.0%10.9%11.2%10.3%13.3%
1.81×1.81×1.44×1.29×0.71×
2.93×2.93×2.70×2.81×2.22×
40.8%39.5%24.8%15.9%13.1%
38.2%38.2%25.3%14.4%11.1%
Open the chart

From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.

KRISHANA₹222.63

Krishana Phoschem Limited

· Unclassified
₹ CrorePeersICEMAKEIRISDOREMEMMPSWARAJMBAPLGKWLIMITEDKRISHNADEFMcap ₹1,376 Cr
ProfitabilityGrowthCreditLiquidityWorking CapitalYield AnalysisDuPont
Ratios — % unless marked ×
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
5-Step DuPont — ROE = Tax Burden × Interest Burden × EBIT Margin × Turnover × Leverage
Tax Burden (Net Income/Pretax) ×0.690.680.700.750.79
Interest Burden (Pretax/EBIT) ×0.910.620.810.910.89
EBIT Margin %13.2810.2711.2510.9211.01
Asset Turnover ×0.711.291.441.811.81
Financial Leverage (Assets/Equity) ×2.222.812.702.932.93
ROE (5-step product, year-end total equity) %13.0815.8724.7739.4640.77
ROE (owners' profit / average owners' equity) %11.0714.3825.2938.1538.15
No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · StandaloneFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.